Galectin-1-driven T cell exclusion in the tumor endothelium promotes immunotherapy resistance. (2019)
Attributed to:
Manipulation of the Complement Pathway to Increase Radiation Sensitivity and Immune Response
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1172/jci129025
PubMed Identifier: 31710313
Publication URI: http://europepmc.org/abstract/MED/31710313
Type: Journal Article/Review
Volume: 129
Parent Publication: The Journal of clinical investigation
Issue: 12
ISSN: 0021-9738